Are anticoagulants still indicated in pulmonary arterial hypertension?
Pulmonary arterial hypertension (PAH) is a type of pulmonary hypertension that is a progressive, fatal disease. Multiple underlying mechanisms for PAH have been identified, including vasoconstriction, intimal proliferation, medial hypertrophy, inflammation, mitochondrial dysfunction, and in situ thr...
Main Authors: | Horst Olschewski, Stuart Rich |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-10-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894018807681 |
Similar Items
-
Overdue to understand anticoagulation in pulmonary arterial hypertension
by: Kishan S. Parikh, et al.
Published: (2018-03-01) -
Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
by: Vasile Foris, et al.
Published: (2023-01-01) -
Anticoagulation in pulmonary arterial hypertension: a decision analysis
by: Arun Jose, et al.
Published: (2019-12-01) -
Exercise Pulmonary Hypertension
by: Katarina Zeder, et al.
Published: (2022-04-01) -
Updated definition of exercise pulmonary hypertension
by: Katarina Zeder, et al.
Published: (2022-12-01)